4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June 2022.
In June 2022, 4D entered administration and its shares were suspended from trading on AIM. At the time, it said it had "no immediate certainty" of how it will repay the USD13.9 million loan facility it has with Oxford Finance LLC.
Later that month, it received written notice from the Nasdaq Stock Market that its securities would be delisted from Nasdaq. Accordingly, trading of its shares was suspended from July 7.
By Sophie Rose, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
